Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Interleukin 6: a functional and structural in vitro modulator of beta-cells from islets of Langerhans.

Buschard K, Aaen K, Horn T, Van Damme J, Bendtzen K.

Autoimmunity. 1990;5(3):185-94.

PMID:
2129751
2.

Effect of fusidic acid on interleukin-1 (IL-1)- and IL-6-induced pancreatic beta-cell functions in rats.

Bendtzen K, Diamant M, Horn T, Pedersen C, Buschard K.

J Endocrinol. 1992 Mar;132(3):345-52.

PMID:
1564418
3.

Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.

Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J.

J Immunol. 1987 Dec 15;139(12):4077-82.

PMID:
3320203
4.

Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans.

Comens PG, Wolf BA, Unanue ER, Lacy PE, McDaniel ML.

Diabetes. 1987 Aug;36(8):963-70.

PMID:
3297891
6.

Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.

Hong TP, Andersen NA, Nielsen K, Karlsen AE, Fantuzzi G, Eizirik DL, Dinarello CA, Mandrup-Poulsen T.

Eur Cytokine Netw. 2000 Jun;11(2):193-205.

PMID:
10903798
7.

The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts.

Xenos ES, Stevens RB, Sutherland DE, Lokeh A, Ansite JD, Casanova D, Gores PF, Platt JL.

Transplantation. 1994 Apr 27;57(8):1208-12.

PMID:
8178348
8.
9.
10.

Functional characteristics of rat pancreatic islets maintained in culture after exposure to human interleukin 1.

Eizirik DL, Strandell E, Bendtzen K, Sandler S.

Diabetes. 1988 Jul;37(7):916-9.

PMID:
3290009
11.

Ultrastructural studies of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity.

Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen K, Nielsen JH, Dinarello CA.

Acta Pathol Microbiol Immunol Scand C. 1987 Apr;95(2):55-63.

PMID:
3300162
12.

Repetitive exposure of pancreatic islets to interleukin-1 beta. An in vitro model of pre-diabetes?

Helqvist S, Zumsteg UW, Spinas GA, Palmer JP, Mandrup-Poulsen T, Egeberg J, Nerup J.

Autoimmunity. 1991;10(4):311-8.

PMID:
1772965
14.

Genetically determined differences in newborn rat islet sensitivity to interleukin-1 in vitro: no association with the diabetes prone phenotype in the BB-rat.

Andersen HU, Mandrup-Poulsen T, Egeberg J, Helqvist S, Nerup J.

Acta Endocrinol (Copenh). 1989 Jan;120(1):92-8. Erratum in: Acta Endocrinol (Copenh) 1989 Mar;120(3):400.

PMID:
2643251
15.

Dual functional effects of interleukin-1beta on purine nucleotides and insulin secretion in rat islets and INS-1 cells.

Meredith M, Rabaglia ME, Corbett JA, Metz SA.

Diabetes. 1996 Dec;45(12):1783-91.

PMID:
8922366
16.

Metabolism and beta-cell function of rat pancreatic islets exposed to human interleukin-1 beta in the presence of a high glucose concentration.

Sandler S, Bendtzen K, Eizirik DL, Strandell E, Welsh M, Welsh N.

Immunol Lett. 1990 Dec;26(3):245-51.

PMID:
2086453
17.

Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis.

Reimers JI, Andersen HU, Mauricio D, Pociot F, Karlsen AE, Petersen JS, Mandrup-Poulsen T, Nerup J.

Diabetes. 1996 Jun;45(6):771-8.

PMID:
8635652
18.
19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk